Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-L Raoul

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 15, 2003
Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development groupE Briasoulis, N Pavlidis, C Terret, et al.
Cancer|January 15, 1995
Sequential chemotherapy and radiotherapy for patients with squamous cell carcinoma of the esophagusE A Le Prise, B C Meunier, P L Etienne, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2017
Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancerC Bascoul-Mollevi, S Gourgou, M-P Galais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patientsY Bécouarn, E Gamelin, B Coudert, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2002
High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancerM Ychou, J L Raoul, F Desseigne, et al.
British Journal of Cancer|October 14, 2010
Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancerT Conroy, Y Yataghène, P L Etienne, et al.
British Journal of Cancer|September 13, 2006
Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trialP Michel, A Adenis, F Di Fiore, et al.
European Journal of Cancer (Oxford, England : 1990)|August 29, 2012
Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601F Ferrand, D Malka, A Bourredjem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinomaM Ducreux, P Rougier, J-P Pignon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patientsJ-F Seitz, J Bennouna, B Paillot, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|October 15, 2003
Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development groupE Briasoulis, N Pavlidis, C Terret, et al.
Cancer|January 15, 1995
Sequential chemotherapy and radiotherapy for patients with squamous cell carcinoma of the esophagusE A Le Prise, B C Meunier, P L Etienne, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2017
Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancerC Bascoul-Mollevi, S Gourgou, M-P Galais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patientsY Bécouarn, E Gamelin, B Coudert, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2002
High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancerM Ychou, J L Raoul, F Desseigne, et al.
British Journal of Cancer|October 14, 2010
Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancerT Conroy, Y Yataghène, P L Etienne, et al.
British Journal of Cancer|September 13, 2006
Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trialP Michel, A Adenis, F Di Fiore, et al.
European Journal of Cancer (Oxford, England : 1990)|August 29, 2012
Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601F Ferrand, D Malka, A Bourredjem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinomaM Ducreux, P Rougier, J-P Pignon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patientsJ-F Seitz, J Bennouna, B Paillot, et al.
Pageof 9